http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102123999-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1eb9667071f40bd09df47436437f0651
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-96
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-96
filingDate 2009-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_866e81887927c509ae0b2e2b7ae011c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eac48157ee81a7f06575b1f90ec1f258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fcdc8ec09f9587e73b55317bed0cccf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0439c1720eaf40d0831de5c5e51ce6a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c1a1343a59192a352c3d1d067607a29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_577f5d09f5d6e5387df9bc26093335f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93b83cdf2d783333a93d87e90ede32e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a8fa6ef4aab80c9f8bc9c14851497ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c48215eb6f0c77b395c0359e82b9059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17851776d488b00ef9139e7801a17047
publicationDate 2011-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102123999-A
titleOfInvention Process for preparing orexin receptor antagonists
abstract The present invention relates to a process for the preparation of pyridylpiperidine compounds which are antagonists of orexin receptors and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases associated with orexin receptors.
priorityDate 2008-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55288375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58332755
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44517263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25128145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592968
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468169027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413587392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413588197
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58332757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413659434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468008439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408007530

Total number of triples: 37.